Advertisement

Pfizer, Teva reach deal to allow generic Viagra

Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

Advertisement
FP Archives|Dec 18, 2013, 08:11:50 IST

New York: Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

Pfizer says Teva will pay an undisclosed royalty for a license to produce a generic version of Viagra, one of New York-based Pfizer's best-selling drugs. Viagra generated about $1.14 billion in US sales last year.

Advertisement

Pfizer's patent protecting Viagra from generic competition expires in April 2020, but Teva will be allowed to launch its generic version Dec. 11, 2017.

Sprout Pharmaceuticals said Wednesday, Dec. 11, 2013, it has reached an impasse with the Food and Drug Administration over its drug, flibanserin. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. AP

Pfizer Inc. had sued Teva in 2010 over the Israeli drugmaker's plans to introduce a generic version of Viagra.

The patent protecting another erectile dysfunction drug, Eli Lilly and Co.'s Cialis, also expires in 2017.

worldMore from World

PTI

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Dec 18, 2013, 08:11:50 IST
Advertisement
Advertisement
Trending Stories

Pakistan's deep state weaponising LeT to counter Asim Munir critic Maulana Fazlur Rehman: Report

A deepening military-terror nexus is reportedly emerging in Pakistan in a bid to neutralise the JUI-F chief, Maulana Fazlur Rehman, after he openly criticised Pakistan's Army Chief Asim Munir.
2 min read
Advertisement
Advertisement
Up Next